Authors
Loading...
Preclinical study reveals that sFRP4 drives platinum resistance and metastasis in gastric cancer, indicating a potential target to overcome chemoresistance.
Chen et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: